Healthcare


 Pfizer and Flynn in the dock for overcharging NHS for anti-epilepsy drugs

Pfizer and Flynn in the dock for overcharging NHS for anti-epilepsy drugs

August 05, 2021 03:43 PM BST| By Suhita Poddar

Summary  The Competition and Markets Authority has accused pharma major Pfizer and Flynn of overcharging for the anti-epileptic drug. Both Pfizer and Flynn exploited a loophole so that they would not face price regulation. The UK's Co.....

 Why have Pfizer and Moderna raised prices for vaccines in the EU?

Why have Pfizer and Moderna raised prices for vaccines in the EU?

August 02, 2021 12:05 PM BST| By Kamalika Ghosh

Summary US-based COVID-19 vaccine manufacturers Pfizer and Moderna increased prices of their vaccines in the latest European Union supply contracts. The terms of the deal for 2.1 billion vaccine doses until 2023 were renegotiated, as the phase .....

 5 top FTSE healthcare stocks below £1

5 top FTSE healthcare stocks below £1

July 28, 2021 11:18 AM BST| By Kamalika Ghosh

Summary  Investors often chose to invest in low-priced stocks in the healthcare sector, as few of such firms will emerge as big gainers in the long term. Events such as successful research attempts or a new drug launch are expected to boos.....

 AstraZeneca’s (LON: AZN) shares and the latest buzz around

AstraZeneca’s (LON: AZN) shares and the latest buzz around

July 20, 2021 11:47 AM BST| By Suhita Poddar

AstraZeneca (LON: AZN), the pharmaceutical major,  which has been news for last some time due to its Covid-19 vaccine, is once again creating buzz after receiving approval in China for its small cell lung cancer drug Imfinzi.  Shares of t.....

 Lens on 5 AIM listed pharma stocks as CMA slaps £260-million fine on drug makers

Lens on 5 AIM listed pharma stocks as CMA slaps £260-million fine on drug makers

July 16, 2021 07:05 AM BST| By Kamalika Ghosh

Summary  CMA slapped fines of over £260 million on drug makers after investigations revealed NHS was overcharged close to a decade for hydrocortisone tablets. Prices of hydrocortisone increased by over 10,000 per cent over the years......

 Which are the 10 biggest FTSE-listed healthcare stocks?

Which are the 10 biggest FTSE-listed healthcare stocks?

July 09, 2021 11:00 AM BST| By Kamalika Ghosh

Summary The pandemic has made people more aware of the importance of research and development in pharmaceuticals, making Healthcare stocks the flavour of the season. AstraZeneca, Dechra Pharmaceuticals are some of the many healthcare stocks tha.....

 Tristel receives three product approvals in the US, Canada, and South Korea

Tristel receives three product approvals in the US, Canada, and South Korea

June 25, 2021 04:25 PM BST| By Suhita Poddar

Summary Tristel received three regulatory approvals for its different categories of product. In the US, the company got approval for surface disinfectant from Environmental Protection Agency. The regulatory approvals will allow the company to .....

 More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

June 23, 2021 05:25 PM BST| By Kamalika Ghosh

GlaxoSmithKline’s (LON:GSK) CEO Emma Walmsley has said that by 2031, the company plans to make sales of over £33 billion and increase adjusted operating profit by 10 per cent in the next half-decade. However, the company plans to slash .....

 EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

June 23, 2021 11:23 AM BST| By Suhita Poddar

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age with neurofibromatosis type 1 (NF1), a rare genetic disease. The drug was approved as per the SPRIN.....

 What are the recent business updates unveiled by MyHealthChecked?

What are the recent business updates unveiled by MyHealthChecked?

June 04, 2021 05:56 PM BST| By Team Kalkine Media

Summary MHC had generated revenue of £26,146 from the launch of the COVID-19 PCR nasal swab test kit in December 2020. The Company had reported a net loss of negative £3.76 million for FY20. MHC had a cash balance of £465,671.....

 Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

May 30, 2021 12:14 AM BST| By Suhita Poddar

Summary Tagrisso has been approved by the European Commission (EC) to treat patients with early-stage epidermal growth factor receptor-mutated non-small cell lung cancer. The EC approval came about due to positive results from the ADAURA phase .....

 GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

May 27, 2021 04:28 PM BST| By Suhita Poddar

Summary GSK, Sanofi launched the final phase III trials of their delayed Covid vaccine. The phase III trial for the vaccine have 35,000 people enrolled, who are 18 years and above from different countries. The trial would study the efficiency .....

 Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura Group agrees to £958 million takeover deal by Carlyle Group

May 26, 2021 05:37 PM BST| By Team Kalkine Media

Vectura Group PLC (LON: VEC) is the healthcare stock listed on the London stock exchange. VEC’s shares have generated a return of 77.83% in the last 12 months. VEC is listed on the FTSE 250 index. On 27 May 2021, the Company will hold its An.....

 Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyle takeover

Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyle takeover

May 26, 2021 04:12 PM BST| By Abhijeet

Summary Vectura Group shares rallied very sharply on Wednesday, 26 May, hitting a 4-year high The drugmaker has agreed on the terms of acquisition with Carlyle Group Bidco will be acquiring all the share capital of Vectura for a cash considera.....

 After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine Research Centre

After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine Research Centre

May 26, 2021 12:53 PM BST| By Team Kalkine Media

Summary The UK has been ranked as world’s top developed country with the best healthcare system overall. Innova, the world’s largest rapid Covid-19 test maker, recently decided to start manufacturing in the UK. Pfizer, one of the w.....

 Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

May 25, 2021 01:11 PM BST| By Suhita Poddar

Summary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for research and manufacturing in the sector post Brexit. Vaccine maker AstraZeneca’s share drop.....

 Vaccination Visibly Helps in Abating Existential Threat to Life

Vaccination Visibly Helps in Abating Existential Threat to Life

May 23, 2021 12:16 AM BST| By Abhijeet

Sumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts initially believed that there could be severe issues with the people who have received the Covid-19.....

 3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine Patents

3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine Patents

May 21, 2021 10:23 AM BST| By Suhita Poddar

Summary The UK and EU are in talks to waive vaccine patents after the US supported the initiative. India and South Africa have long been asking for waiving patents under the World Trade Organisation’s Trade-Related Aspects of Intellectual.....

 Oxford Biomedica Shares Surge as Revenue Expectation from AstraZeneca Doubles

Oxford Biomedica Shares Surge as Revenue Expectation from AstraZeneca Doubles

May 18, 2021 03:59 PM BST| By Abhijeet

Summary Oxford Biomedica on Tuesday almost doubled its revenue expectation from AstraZeneca Plc, as it bagged more batches vaccine order. Biomedica raised its revenue guidance from over £50 million to over £100 million from AstraZen.....

 GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials

GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials

May 18, 2021 11:37 AM BST| By Suhita Poddar

 Summary After an initial setback, the companies reported success for their Covid-19 vaccine candidate. The candidate’s global phase III study is likely to begin in the next few weeks. The vaccine could get approval by the end of th.....

Recent Articles






Investing Tips

Previous Next